Posted by Michael Wonder on 11 Apr 2023
ICER publishes 2023 research protocol for assessing unsupported price increases on prescription drugs
11 April 2023 - Annual unsupported price increase report to be published on December 12.
The ICER today posted a protocol outlining how we will conduct our next analysis of “unsupported price increases” among prescription drugs within the US market. This initiative will identify the 10 net price increases occurring in 2022 that had the largest impact on national drug spending and determine whether new clinical evidence existed that could support those price increases.
